Faculty Bibliography

OBJECTIVE:The aim of this study was to determine predictors of the minimum clinically important difference (MCID) in the Neck Disability Index (NDI) following cervical spinal deformity surgery. METHODS:A retrospective review was performed of a prospective, multicenter adult cervical spinal deformity database. All patients had baseline and 1-year NDI scores. Patients met MCID with an improvement of NDI by 7 points between baseline and 1 year, as previously established. Baseline demographics, comorbidities, and both baseline and 1-year spinopelvic parameters were evaluated for statistical significance in a univariate logistic regression analysis. Significant variables, in addition to baseline NDI, were analyzed in a multivariable logistic regression model by backward selection with Akaike information criterion minimization. RESULTS:A total of 122 patients were included with a median age of 62 (IQR 56, 69) years; 62% of patients were female. Of the 122 patients, 72 (59%) achieved NDI MCID at 1 year. Predictors of achieving MCID on univariate analysis included a lower Charlson Comorbidity Index (CCI) total score (OR 0.70, p = 0.03), depression as a comorbidity (OR 2.9, p = 0.02), lower C2 tilt at the 1-year follow-up (OR 0.92, p = 0.02), and a greater difference between 1-year postoperative C2-7 sagittal vertical axis (SVA) and preoperative C2-7 SVA (OR 0.98, p = 0.0495). On multivariable logistic regression analysis, predictors of achieving MCID included a lower CCI (OR 0.62, p = 0.03), depression as a comorbidity (OR 3.1, p = 0.059), a greater change in C2-7 SVA at the 1-year follow-up compared with baseline (OR 0.97, p = 0.055), and baseline NDI (OR 1.02, p = 0.24) with an area under the curve of 0.74. CONCLUSIONS:The best-fit multivariable model included higher baseline NDI, a greater change in C2-7 SVA, patient-reported baseline depression, and lower CCI as important factors in predicting NDI MCID.

OBJECTIVE:The objective of this study was to determine whether increased cell saver (CS) salvage transfusion to estimated blood loss (EBL) ratio (CS:EBL) is a driver in the development of cardiopulmonary (CP) and/or renal complications. METHODS:Patients with adult spinal deformity (ASD) enrolled in a multicenter, observational prospective study from 13 spinal deformity centers in North America were queried. Eligible participants met at least one of the following radiographic and/or procedural inclusion criteria: pelvic incidence-lumbar lordosis mismatch ≥ 25°, T1 pelvic angle ≥ 30°, sagittal vertical axis ≥ 15 cm, thoracic scoliosis ≥ 70°, thoracolumbar/lumbar scoliosis ≥ 50°, global coronal malalignment ≥ 7 cm, having undergone a 3-column osteotomy, spinal fusion ≥ 12 levels, and/or age ≥ 65 years with ≥ 7 levels of instrumentation. Patients were dichotomized based on whether their CS:EBL was ≥ or < 0.33. Patients who did not have CS transfused intraoperatively were excluded. Key outcomes included renal and CP-related medical complications. Patient characteristics, preoperative laboratory results, operative data, and radiographic parameters were compared using appropriate statistical tests. A conceptual multivariable logistic regression model was built to assess risk factors associated with the primary outcome. RESULTS:Four hundred six patients were included in this analysis, including 10.6% (n = 43) with a CS:EBL ≥ 0.33 and 89.4% (n = 363) with a CS:EBL < 0.33. The patients with a CS:EBL ≥ 0.33 were significantly older (mean 66.2 [SD 12.2] vs 58.9 [SD 16.4] years, p = 0.0007), experienced less EBL intraoperatively (mean 1048.3 [SD 852.2] vs 1695.6 [SD 1295.3] ml, p < 0.0001), had fewer total instrumented levels (mean 12.2 [SD 3.3] vs 14.1 [SD 3.6] levels, p = 0.0001), had fewer posterior column osteotomies performed (72.1% vs 86.8%, p = 0.0103), and had less major coronal Cobb angle correction (mean -17.0° [SD 14.6°] vs -22.7° [SD 16.7°], p = 0.0373). Despite comparable transfusion rates, patients with a CS:EBL ≥ 0.33 had fewer packed red blood cell (RBC), fresh frozen plasma, and platelet units transfused intraoperatively (p < 0.05). No significant differences were observed among overall CP and renal complications. However, when stratifying CP complications by type, patients with a CS:EBL ≥ 0.33 experienced a significantly greater rate of pulmonary embolisms (PEs; 9.3% vs 1.4%, p = 0.0093) within 30 days of surgery. A multivariable logistic regression model adjusted for the significant differences between the two groups found a CS:EBL ≥ 0.33 to be an independent risk factor for the development of a PE, conferring an odds ratio of 6.57 (95% CI 1.75-24.66) with excellent model diagnostics (model p value = 0.0031, area under the receiver operating characteristic curve = 0.92). CONCLUSIONS:Patients with a high CS:EBL were at a significantly greater risk of developing a PE within the early postoperative period independent of blood loss and operative complexity. The findings support the re-evaluation of salvaged RBC use in this patient population based on perceived benefits.

PURPOSE/OBJECTIVE:To compare the impact of lumbar lordosis correction achieved by cephalad versus caudal distribution on radiographic alignment and surgical outcomes among adult spinal deformity (ASD) patients. METHODS:Patients who underwent ASD surgery with uppermost instrumented vertebrae (UIV) at or above L1, had preoperative pelvic incidence-lumbar lordosis (PI-LL) > 10°, and had full-body radiographs available were included. Eligible patients were categorized by the focus of lordosis correction: caudal (L4-S1 lordosis between 35 and 45°) and cephalad lordosis-based correction. Patient demographics, preoperative and 2 years spinopelvic alignment and PROMs, and 2 years postoperative surgical complications were compared. RESULTS:In total, 187 (111 caudal and 76 cephalad) patients were included, with mean age of 66.2 years, 78.6% female, and mean frailty score of 3.6. Caudally-restored patients often had an upper thoracic UIV, sacrum/ilium LIV, longer length of fusion, and no lateral lumbar interbody fusion (LLIF) while cephaladly-restored patients had two or more LLIFs above L4 (p < 0.001). Preoperatively, there were no significant differences in radiographic alignment and PROMs between the two groups (p > 0.02). Two years postoperatively, caudally-restored patients had higher L1-S1 LL (p = 0.015) and L4-S1 LL (p < 0.001), and lower PI-LL (p = 0.039) and SVA (p = 0.001). In addition, they had higher SRS-22 activity (p = 0.045), pain (p = 0.047), appearance (p = 0.046), and total (p = 0.016) scores. Finally, they had lower rates of sensory deficits (p < 0.001), motor deficits (p = 0.003), implant failure (p = 0.092), and reoperation (p = 0.020). CONCLUSION/CONCLUSIONS:Caudal lordosis-based correction of spinal deformity patients was associated with higher PROMs and lower rates of neurologic deficits, implant failure, and revisions at 2 years. These findings, while subject to unmeasured confounding, indicate that great caution should be taken when considering cephalad-based correction of ASD.

PURPOSE/OBJECTIVE:A subset of adult spinal deformity (ASD) patients undergoing corrective surgery receive a disproportionate level of medical resources and incur greater costs. We examined the characteristics of such super-utilizers of health care resources among ASD patients. METHODS:This prospective, multicenter study analyzed data from ASD patients with > 4 levels of spinal fusion and a minimum 2-year follow-up. Index and total episode-of-care (EOC) costs in 2022 US dollars were calculated using average itemized direct costs obtained from administrative hospital records. Patients with total 2-year EOC cost > 90th percentile were considered super-utilizers, the characteristics of which we identified through a multivariate generalized logistic model. RESULTS:Of 1299 eligible patients, mean age was 60 years, 73% were female and 92% were Caucasian. Super-utilizers were older (+2.1 years; p = 0.012), had greater depression (34.2 vs 25.7%; p = 0.03), increased frailty (p = 0.009) comorbidities (p = 0.005), higher reoperation rates (54.4 vs 15.0%; p < 0.001), hospital length of stay (+ 3 days; p < 0.0001), higher surgical invasiveness (+28.6; p < 0.001), more vertebrae fused (+ 3; p < 0.0001); interbody fusions (80 vs 55%; p < 0.0001), bone morphogenetic protein (BMP) use (87.3 vs 69.4%; p = 0.0001), operative time (+91 min; p < 0.0001), and blood loss (+620 mL; p < 0.0001) compared to other ASD patients. Index cost was 65% (p < 0.0001), and cost/quality-adjusted life-year was three times higher among super-utilizers. CONCLUSION/CONCLUSIONS:ASD patients with depression who undergo more complex or revision spinal surgical procedures are more likely to be super-utilizers. Identifying likely super-utilizers within the ASD population may enable targeted interventions and preoperative planning to reduce unnecessary costs, while improving patient outcomes.

OBJECTIVE:The aim of this study was to determine the rate of postoperative new-onset sacroiliac joint pain (SIJP) following adult spinal deformity (ASD) surgery with pelvic fixation. METHODS:Patients undergoing ASD surgery with pelvic fixation, without baseline SIJP, and with a minimum 1-year follow-up were included. Patients were screened for SIJP by self-reported buttock/groin pain and/or posterior superior iliac spine (PSIS) pain scores ≥ 4. Patients with positive results on questionnaires were indicated for an SIJ examination consisting of 5 provocative maneuvers with ≥ 3 positive examination findings considered to be indicative of SIJP. Types of pelvic fixation were then compared for rates of postoperative SIJP. RESULTS:A total of 346 patients were identified, with mean age of 65 (SD 10) years and BMI of 28 (SD 5); 71% of patients were female. Thirteen patients (4%) underwent SIJ fusion at the index procedure. At the 1-year follow-up, 82 patients (24%) had positive screening responses for SIJP on the questionnaire; 63 underwent an SIJ examination and only 3 patients (1%) had a positive result. At the 2-year follow-up, 138 patients were administered the SIJP screening questionnaire; 31 (22%) had a positive questionnaire response for SIJP, 17 underwent an SIJ examination, and only 2 patients (1%) had a positive result. There was no difference in SIJP between patients with traditional iliac fixation (n = 162, 0% at 1 and 2 years) and S2-alar-iliac screws (n = 184), where 2% developed SIJP by 1 (p = 0.25) and 2 (p = 0.52) years, respectively. There was also no difference in SIJP between patients with 4 points of pelvic fixation (n = 85, 0% at 1 and 2 years) and patients with fewer than 4 points of pelvic fixation (n = 261), where 1% (p = 0.57) and 2% (p > 0.99) developed SIJP at 1 and 2 years, respectively. Of the 79 patients with iliac crest harvesting, none developed SIJP at the 1- or 2-year follow-up. CONCLUSIONS:Based on examination, the incidence of de novo SIJP following ASD surgery with pelvic fixation is low: only 1% at the 1- and 2-year follow-ups. The large discrepancy between at least moderate regional reported pain but a negative provocative examination warrants further investigation as to the source of substantial pain in nearly one-quarter of ASD patients postoperatively.

STUDY DESIGN/METHODS:Retrospective analysis of retrospectively collected data. OBJECTIVE:To determine the effects of preoperative nonsteroidal anti-inflammatory drug (NSAID) use on estimated blood loss (EBL) and postoperative drain output in TLIF procedures. SUMMARY OF BACKGROUND DATA/BACKGROUND:Current standards of care recommend patients prescribed NSAIDs for chronic lower back pain discontinue NSAIDs at least 1 week before spine fusion surgery. The literature surrounding the effects of preoperative NSAID use is unclear, however, with dissonant findings regarding postoperative blood loss and complications. METHODS:A retrospective case review was performed on 429 cases of 1-level or 2-level TLIF, with patient NSAID use recorded within 3 days of surgery, at a single institution. Linear and logistic regressions were used to assess associations between NSAID use, patient and surgical characteristics, EBL, and drain output. RESULTS:NSAID use was significantly positively associated with drain output (P=0.03), with an approximate increase of 21±9.7 mL/day but no significant association with any postoperative complications (P=0.77). Drain output also had significant, independent positive associations with patient age (P=0.007), male sex (P<0.001), and a number of levels fused (P<0.001), and significant negative associations with robot-assisted (P<0.001) and minimally invasive (P=0.04) procedures. No significant association was detected between NSAID use and EBL (P=0.21), though EBL had significant positive associations with operative time (P<0.001) and levels fused (P<0.001), and multiple NSAIDs had a significant positive association with EBL (P<0.001). CONCLUSIONS:NSAID use had a statistically significant, but small, effect on drain output and no detectable effect on postoperative complications within 3 days of TLIF procedures, suggesting most patients can safely continue NSAID use up until their date of surgery. Future studies should further delineate the effects of preoperative NSAID use, such that a more refined risk profile could be developed from patient and surgical characteristics and NSAID use information.

BACKGROUND AND OBJECTIVES/OBJECTIVE:Thoracolumbar spinal deformity frequently coexists with cervical spine deformity (CD) and lower extremity osteoarthritis (OA), complicating management and compounding functional disability. This study investigates the additive burden of these conditions on patient-reported outcome measures (PROMs). METHODS:This retrospective analysis assessed primary thoracolumbar deformity patients undergoing corrective surgery. Demographics, spinopelvic alignment, and PROMs were characterized. Severe CD was defined by ≥1 Ames criterion. Hip (HOA) and knee (KOA) OA were defined as Kellgren-Lawrence grade ≥3. Hierarchical regression and mixed-effects models evaluated the incremental and longitudinal impacts of these conditions on PROMs. RESULTS:Among 816 patients (mean age 60.4 years, 67.1% female), 24.8% had CD, 43.7% HOA, and 40.4% KOA at baseline. Regression revealed that HOA worsened Oswestry Disability Index (ODI) total (R2 = 0.056, P = .008), ODI Walking (R2 = 0.121, P <.001), Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function (R2 = 0.108, P = .013), and Veterans RAND 12-Item Health Survey (VR-12) Physical Component Score (PCS) (R2 = 0.098, P = .022). KOA primarily affected pain and psychosocial outcomes, including ODI Pain (R2 = 0.033, P = .001), PROMIS Depression (R2 = 0.018, P = .002), Scoliosis Research Society-22 Mental (R2 = 0.033, P = .004), and VR-12 Mental Component Score (R2 = 0.023, P = .025). CD contributed to ODI (R2 = 0.063, P = .018) and Scoliosis Research Society-22 Activity (R2 = 0.044, P = .032). Mixed-effects models showed improvements in all PROMs from baseline to 2-year follow-up (P <.001). However, HOA reduced improvements in ODI (3.41 points, P = .009), PROMIS Physical Function (1.37 points, P = .009), and VR-12 PCS (2.21 points, P = .003). KOA was associated with reduced walking tolerance (ODI Walking: 0.21 points, P = .020) and increased psychological burden (PROMIS Anxiety: 1.71 points, P = .007; VR-12 MCS: 2.01 points, P = .027). CD affected ODI Walking (0.51 points, P = .007) and VR-12 PCS (3.19 points, P = .043). CONCLUSION/CONCLUSIONS:HOA patients undergoing deformity correction have worse preoperative physical disability and impaired postoperative functional recovery. KOA is associated with greater psychological burden. Severe CD has smaller physical impact. These findings highlight the need for individualized, multidisciplinary management strategies, with particular emphasis on early identification and targeted intervention for hip pathology to optimize outcomes.

OBJECTIVE:While health-related quality of life (HRQOL) measures have been extensively quantified in cervical deformity (CD), this clinical dimension has not yet been fully integrated into understanding CD radiographic subtypes prior to surgery. The aim of this study was to identify distinct patterns of HRQOL deficits among patients with CD by focusing on clinical scores and to examine the association of these patterns with radiographic morphotypes of CD. METHODS:This was a retrospective analysis of a prospective multicenter database of patients with CD aged 18 years or older. Patient-reported outcome measures consisted of the Neck Disability Index (NDI), modified Japanese Orthopaedic Association (mJOA) scale, and Swallowing Quality of Life (SWAL-QOL) questionnaire. After performing a principal component analysis on the individual questions of the NDI, mJOA, and SWAL-QOL, 4 factors with eigenvalues > 1 were retained and included in a cluster analysis to assign patients into homogeneous groups of outcomes. Moreover, a subgroup of patients with severe deformity was described and analyzed. RESULTS:Overall, 134 patients (59% female, mean age ± SD 60.9 ± 10.8 years) were included in this analysis. The mean HRQOL scores were NDI, 49.1 ± 17.6; mJOA, 13.5 ± 2.7; and EQ-5D, 0.7 ± 0.1). The factor analysis involving NDI, SWAL-QOL, and mJOA revealed 4 clusters. Cluster A represented patients with a predominant sleep problem. Cluster B was patients with the lowest neck disability. Cluster C represented the most disabled patients in terms of dysphagia and neck disability. Cluster D represented patients with myelopathy. Among the 71 patients with severe deformity, the distribution of cervical morphotypes significantly differed across the 4 clusters of disability (p = 0.009). Cluster C mainly consisted of patients with cervicothoracic deformity (66.7%, p = 0.002). Cluster D had a large proportion of patients (66.7%) with focal deformity (p = 0.007). In clusters A and B, 57.9% and 46.4% of patients, respectively, presented with "flat neck" deformity (p = 0.02). CONCLUSIONS:Distinct patterns of HRQOL deficits were observed across a heterogeneous population of patients with CD, and these patterns were associated with specific radiographic morphotypes. These findings provide a framework for the next generation of CD classification, wherein HRQOL measures are combined with radiographic parameters.

STUDY DESIGN/METHODS:Retrospective cohort. OBJECTIVE:The ISSG-AO Spinal Deformity Complication Classification System (SDCCS) predicts Diagnosis Related Group (DRG) coding and cost. BACKGROUND:Inconsistent definitions of complications contribute to variation in reported surgical complication rates. Incorrect complication reporting can lead to over or under DRG reimbursement. The ISSG-AO SDCCS provides improved complication reporting reproducibility and may help predict complication costs. METHODS:ASD patients were grouped into: DRG without complication or comorbidity (CC) or Major CC (MCC) (DRGs 455 & 458), with CC (DRGs 454 & 457), and with MCC (DRGs 453 & 456). Complications were graded by intervention severity per ISSG-AO system: grade 0 (none), 1 (mild-e.g., med change), 2 (moderate-e.g., ICU), 3 (severe-e.g., reoperation). Cost were based on Medicare inpatient prospective payment system (IPSS, Medicare Allowable rate). A multinomial logistic model identified key predictors of DRG assignment by complication grades. RESULTS:Of the 675 patients, 14% were in DRGs without CC/MCC, 71% in DRGs with CC, and 15% were DRGs with MCC. Patients with complications requiring intervention mostly fell into the higher DRG categories (97%). Patients who received an intervention are approximately 6.75 (2.01-22.75, P<.0021) times more likely to be classified under DRG with CC and 15.72 (95% CI, 4.23-58.45, P<.0001) times more likely to be classified with DRG with MCC compared to those who did not receive an intervention. Each unit increase in Edmonton Frailty Score raises the odds of being in DRG with MCC by 1.24 (95% CI 1.04-1.48, P 0.017). Similar trends were seen for OR time and LOS. Reimbursement showed incremental increase from $49.5K to $56K to $70K across DRG categories. CONCLUSIONS:Patients with elevated ISSG-AO scores are more likely to be categorized into higher DRGs, experience extended lengths of stay and generate greater healthcare expenditures. The ISSG-AO SDCCS predicts DRG thereby helping standardize complication reporting.